Install
Daily news and insights on the fast-growing longevity market – antiaging, biotech, research, investment, supplements and rejuvenation therapies. First Longevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest. First Longevity Limited does
- 60articles · 30d
- 3+ day agolatest article
- Aug 15, 2026earliest in window
- 95%with images
- 332avg words
- Medical 51
- Health & Wellness 47
- Health 28
- Science & Technology 26
- Science & Nature 8
- Business & Industrial 7
- Economy, Business & Finance 5
- Beauty & Fitness 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Celularity lands $300m MuseCell manufacturing deal
6+ day, 10+ hour ago (344+ words) Deals in cell therapy tend to get announced in two flavors: the kind built around a single drug, and the kind built around infrastructure. This unglamorous plumbing decides whether any of these therapies can actually be made at scale. The…...
Will AI Make Death Optional? - Longevity.Technology UNLOCKED
6+ day, 13+ hour ago (241+ words) What would have to be true for AI to genuinely change the trajectory of human aging? The answer is more complicated than simply discovering an “anti-aging drug.” AI is already compressing parts of drug discovery, with one AI-designed candidate reaching…...
AI hunts new uses for Phase 3 metabolic drug
1+ week, 4+ day ago (523+ words) longevity.technology AI hunts new uses for Phase 3 metabolic drug Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: THPharm already has…...
New patent strengthens Alterity’s Parkinson’s investment
1+ week, 4+ day ago (247+ words) Patents rarely make headlines outside the biotech trade press, but for a clinical-stage company preparing to enter a pivotal trial, a strong patent estate can matter as much as the data itself. Alterity Therapeutics has just secured one of those…...
The $51M Bet to Make the Doctor Obsolete
2+ week, 6+ day ago (428+ words) What if the future of healthcare is not a better hospital, but a system designed to keep you out of one? Phil Newman sits down with Max Marchione, co-founder and CEO of Superpower, to explore his vision for a preventive…...
Whole-body MRI is leaving the biohacker bubble
3+ week, 2+ day ago (447+ words) Longevity.Technology Whole-body MRI is leaving the biohacker bubble Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: EHE Health’s partnership with…...
Network Bio launches with $50m for biological AI
3+ week, 4+ day ago (869+ words) Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life. With a keen interest in all things geroscience,…...
Can AI put the cell back together?
3+ week, 5+ day ago (440+ words) GenBio AI has launched AIDO Cell, a virtual cell system designed to simulate human cellular behavior across multiple biological layers within a single computational environment – allowing researchers to perturb DNA, RNA or proteins and model how the consequences propagate through…...